药物诱发性无菌性脑膜炎:法国药物警戒数据库329例分析
该研究基于法国药物警戒数据库1985年1月1日至2017年3月8日的数据,分析329例药物诱发性无菌性脑膜炎(DIAM)病例及429个可疑药物。对203例记录完整病例(含282个药物)的分析显示,主要可疑药物类别为静脉多价免疫球蛋白、非甾体抗炎药(NSAIDs)、疫苗、抗菌药物、鞘内抗代谢药、糖皮质激素及镇痛/麻醉药(NSAIDs除外)。脑脊液以淋巴细胞性(33.0%)和化脓性(44.8%)为主,96%病例结局良好。
要点
- 静脉多价免疫球蛋白、NSAIDs、疫苗和抗菌药物是DIAM最常见可疑药物。
- DIAM脑脊液表现多样,淋巴细胞性和化脓性为主,无法据此区分可疑药物。
- 绝大多数DIAM病例结局良好,完全恢复或仅轻微残留症状。
核心结论
- DIAM最常见可疑药物为静脉多价免疫球蛋白、NSAIDs、疫苗和抗菌药物,生物学特征无法区分这些药物。
研究设计与样本
- 基于法国药物警戒数据库1985年1月1日至2017年3月8日数据的回顾性分析,共纳入329例无菌性脑膜炎病例和429个可疑药物。
主要发现
- 203例记录完整病例(含282个药物)中,主要可疑药物类别为静脉多价免疫球蛋白、NSAIDs、疫苗、抗菌药物、鞘内抗代谢药、糖皮质激素及镇痛/麻醉药(NSAIDs除外)。
- 脑脊液淋巴细胞性占33.0%,化脓性占44.8%,其余为混合性或数据缺失。
- 96%的DIAM病例报告结局良好,完全恢复或仅轻微残留症状。
局限性
- 需进一步研究以更好地理解DIAM的病理生理机制。
- 持续丰富药物警戒数据库对于识别新信号和帮助临床医生理解DIAM至关重要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Drug-induced aseptic meningitis (DIAM) is an adverse drug reaction of exclusion; only few studies have addressed this iatrogenic disease. The aim was to characterize DIAM and to identify suspected drugs. METHODS: Data were collected from the analysis of the French Pharmacovigilance Database from inception (1 January 1985) to 8 March 2017. All cases were initially analysed according to the French imputability method by institutional pharmacologists (clinicians or pharmacists). Further analyses of well documented cases were then performed. RESULTS: In this study, 329 cases of aseptic meningitis were retrieved from the French Pharmacovigilance Database for a total of 429 suspected drugs. Analysis of 203 well documented cases, including 282 drugs, showed that the main reported classes were intravenous polyvalent immunoglobulin, nonsteroidal anti-inflammatory drugs (NSAIDs), vaccines, antimicrobials, intrathecal antimetabolites, corticosteroids and antalgics/anaesthetics (except NSAIDs). Lymphocytic (33.0%) and purulent (44.8%) meningitis represented the majority of cases of aseptic meningitis. In other cases, the cerebrospinal fluid was mixed (45-55% of neutrophils +45-55% of lymphocytes) or data about cerebrospinal fluid composition were lacking. Most DIAM cases (96%) had a favourable reported outcome with full recovery or minimal residual symptoms. CONCLUSION: The most frequently involved drugs in DIAM were intravenous polyvalent immunoglobulin, NSAIDs, vaccines, and antimicrobials and this without being able to differentiate them in terms of biological characteristics. Although further studies are needed to better understand the pathophysiological mechanisms of DIAM, a continuous enrichment of pharmacovigilance databases is essential to identify new signals and to help clinicians in the understanding of DIAM.
引用
- Bihan K, Weiss N, Théophile H, et al. Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis. Br J Clin Pharmacol. 2019. PMID: 31318079. doi:10.1111/bcp.14073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。